MCE Direct Visualization of Drug Behavior in Upper-gastrointestinal Tract
Feasibility of Using Magnetically-controlled Capsule Endoscopy for Direct Visualization of Drug Behavior in Upper-gastrointestinal Tract
1 other identifier
observational
20
1 country
1
Brief Summary
The investigators aim to explore the feasibility of MCE in direct, real-time visualization of drug behavior in upper-gastrointestinal tract, which presented by the adhesion, distribution, and dissipation characteristics of dyed sucralfate gel.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 3, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 22, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 14, 2020
CompletedFirst Submitted
Initial submission to the registry
March 27, 2020
CompletedFirst Posted
Study publicly available on registry
March 31, 2020
CompletedApril 28, 2020
April 1, 2020
12 months
March 27, 2020
April 26, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Sucralfate gel adhesion behavior in the fasted gastric cavity
The adhesion time was recorded from the sucralfate gel entered the stomach to all sucralfate adhered to the gastric wall.
180 minutes
Sucralfate gel distribution behavior in the fasted gastric cavity
The distribution area of sucralfate gel was measured by selecting images of six primary anatomic landmarks (cardia, fundus, body, angulus, antrum, and pylorus) at different times, the images were imported into MATLAB software to calculate the area of sucrafate gel. The dynamic changes of distribution area of sucralfate gel over the time were analyzed and performed with GraphPad Prism.
0, 30, 60, 90, 150, 180 min after dyed sucralfate gel enter the stomach
Sucralfate gel dissipation behavior in the fasted gastric cavity
The dissipation time was evaluated by calculating the times between sucralfate gel entered the stomach and adhered sucralfate disappeared completely.
180 minutes
Secondary Outcomes (2)
Number of Participants with complications of MCE
2 weeks
Discomfort scores of participants during the procedure
during the procedure
Study Arms (2)
Abdominal symptoms group
The investigators selected 10 subjects (male: female = 1: 1) from patients with a recent history of upper-gastrointestinal symptoms who met the indication of taking sucralfate suspension gel
Healthy control group
The investigators selected another 10 subjects (male: female = 1: 1) from healthy volunteers.
Interventions
The subjects swallowed the capsule with water in the left lateral position. When capsule enter stomach cavity, subject was asked to sit up and ingested 4 g aerogenic powder with 5 ml water to distend the stomach, and performed gastric baseline examinations to identify the lesions. After baseline examination, subjects ingested dyed sucralfate gel and performed the first-time examination. The examination was repeated at 30 min intervals, until dyed sucralfate gel disappeared completely.
Eligibility Criteria
Volunteers who agreed to participate in the feasibility examination of MCE direct visualization of sucralfate gel behavior in fasted stomach.
You may qualify if:
- With or without gastrointestinal complaints
- Scheduled to undergo a capsule endoscopy for both stomach and small bowel
- Signed the informed consents before joining this study
You may not qualify if:
- Suspected or known gastrointestinal stenosis
- Obstruction or other known risk factors for capsule retention
- Pregnancy or suspected pregnancy
- Pacemakers or electromedical devices implanted
- Any other contraindications determined by endoscopists
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Changhai Hospital
Shanghai, 200433, China
Related Publications (1)
Wang YC, Pan J, Jiang B, Qian YY, Qiu XO, Yuan YZ, Li ZS, Liao Z. Direct visualization of drug behaviors in the upper GI tract via magnetically controlled capsule endoscopy. VideoGIE. 2021 May 28;6(7):333-338. doi: 10.1016/j.vgie.2021.04.004. eCollection 2021 Jul.
PMID: 34278100DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Zhuan Liao
Changhai Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D., Associate Professor, Associate Chief Physician
Study Record Dates
First Submitted
March 27, 2020
First Posted
March 31, 2020
Study Start
November 3, 2018
Primary Completion
October 22, 2019
Study Completion
February 14, 2020
Last Updated
April 28, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will not share